Skip to content

Living With Cervical Cancer: Assessing Utilities Associated With Common Treatment Complications

Living With Cervical Cancer: Assessing Utilities Associated With Common Treatment Complications

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01039493
Enrollment
40
Registered
2009-12-25
Start date
2010-02-28
Completion date
2010-08-31
Last updated
2015-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer

Brief summary

The objective of this study is to establish patient preferences in regards to common complications of cervical cancer treatments, and to compare these preferences to those of medical providers who care for cervical cancer patients. These preferences will be determined via a interview using the Standard Gamble, which is a well-recognized method for establishing utilities.

Interventions

None listed

Sponsors

University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 61 Years
Healthy volunteers
No

Inclusion criteria

* A subject has to have been diagnosed with early cervical cancer (Stage I or II) within the last 3 years and/or take care of patients with cervical cancer and identify her or himself as one of the following: gynecologic oncologist, radiation oncologist, physician's assistant or nurse. * Subjects must be ≥18 and \<61 years old.

Exclusion criteria

* Subjects who are unable to read and speak English proficiently will be excluded. Proficiency will be assessed by the investigator enrolling patients. * Subjects who do not have capacity to consent will not be included in this study. * Subjects may not be investigators on this study.

Design outcomes

Primary

MeasureTime frame
Utilities of complications associated with cervical cancer treatment.At time of interview

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026